Norton Healthcare
Norton Healthcare
Louisville, Kentucky, United States14 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Cancer, Castration-Resistant, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT03748641 | |
| IVUS CHIP UPP Registry | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2026-09-23 | NCT06625801 | |
| Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease | central nervous system disorder, essential tremor, movement disorder, nervous system disorder | Recruiting | Not stated | 2026-09-18 | NCT07428447 | |
| An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 3 | 2026-09-02 | NCT07365332 | |
| INSPIRE Pipeline™ Shield Post Approval Study | Aneurysm, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorder | Active, not recruiting | Not stated | 2026-08-10 | NCT05071963 | |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, triple-negative breast carcinoma, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2026-06-04 | NCT04300556 | |
| Esophageal and Gastric Registry and Biorepository | Deglutition Disorders, Digestive System Diseases, digestive system disorder, dyskinesia of esophagus, esophageal disorder, gastroesophageal reflux disease | Recruiting | Not stated | 2026-05-04 | NCT05180253 | |
| Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-03-24 | NCT05478304 | |
| ATrial Tachycardia PAcing Therapy in Congenital Heart | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, atrial tachycardia, cardiovascular disorder, congenital heart disease, heart disorder | Recruiting | Not stated | 2026-03-13 | NCT03209583 | |
| Long-Acting Injectable HIV PrEP PROs | HIV Pre-exposure Prophylaxis | Not yet recruiting | Not stated | 2026-01-30 | NCT07379658 | |
| A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer | Carcinoma, Ductal, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Active, not recruiting | Not stated | 2025-02-12 | NCT03899649 | |
| A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | Carcinoma, Ductal, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Active, not recruiting | Phase 3 | 2025-02-12 | NCT03899636 | |
| Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, malignant glioma, neoplasm, neuroepithelial neoplasm, oligodendroglioma, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2024-11-29 | NCT05561374 | |
| VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems | Digestive System Diseases, autoimmune disease, autonomic nervous system disorder, brain disorder, central nervous system disorder, digestive system disorder, epilepsy, gastroenteritis, immune system disorder, inflammatory bowel disease, intestinal disorder, nervous system disorder, primary dysautonomia | Recruiting | Not applicable | 2024-11-25 | NCT03953768 |